glp-1 receptor agonists adverse effects of Clinical Focus on GLP-1 Agonists

Given the wide use of these drugs, these adverse events, although rare, must be considered by patients thinking about using them for weight loss, Mohit Sodhi, MSc, a fourth-year medical student at the University of British Columbia, said in a related press release

6 Similarly, as GLP-1RAs significantly reduced the risk of MACE, mortality from CV causes, when compared with placebo, ADA has suggested that these medications should be used in patients with underlying cardiovascular disease

I guess you can think of this as an extension of our moderation molecule hypothesis

12-14 Exenatide is available in pen form, potentially making dosing and administration more convenient ( TABLE 1 )

Finally, it is important to highlight the immunomodulatory effects of tirzepatide